Jessica Su, MS, ScD


Jessica Su, MS, ScD

Dr. Lasky-Su is an Associate Professor in Medicine and Associate Statistician at Harvard Medical School and Brigham and Women’s Hospital. Over the last 21 years, Dr. Lasky-Su has focused on the analysis of genetics, genomics, and metabolomics data of various complex diseases with a primary focus on respiratory disease over the last 16 years. The accumulation of these efforts has resulted in a productive track record of over 170 original research articles. Through the funding of multiple metabolomics-related grants, Dr. Lasky-Su has developed a “metabolomic epidemiology” research program at the Channing Division of Network Medicine that has been highly successful and synergistic in nature, and has developed into one of the largest and most impactful groups of metabolomic epidemiologists with a strong national and international presence and comprehensive publication record. In addition to using metabolomics to study the etiology of several complex diseases, including body mass index, asthma, allergies, autism, bacteremia, and macular degeneration, Dr. Lasky-Su has also focused on using metabolomics data in conjunction with other omics data to study disease etiology using several approaches to integrative omics. Most recently, Dr. Lasky-Su is applying her expertise in metabolomics to understand the biologic determinants of a severe COVID-19 response and to develop a predictive prognostic test to identify those at risk of a severe COVID-19 response. She serves in national and international leadership capacities, including the President of the Metabolomics Society, the chairman of the Consortium of METabolomic Studies (COMETS), and a governing board member of the “Metabolomics Workbench.”